Discovery of CASP8 as a potential biomarker for high-risk prostate cancer through a high-multiplex immunoassay

Prostate cancer remains the most common non-cutaneous malignancy among men in the United States. To discover potential serum-based biomarkers for high-risk prostate cancer, we performed a high-multiplex immunoassay utilizing patient-matched pre-operative and post-operative serum samples from ten men...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shiqin, Garcia-Marques, Fernando, Zhang, Chiyuan Amy, Lee, Jordan John, Nolley, Rosalie, Shen, Michelle, Hsu, En-Chi, Aslan, Merve, Koul, Kashyap, Pitteri, Sharon J., Brooks, James D., Stoyanova, Tanya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027881/
https://www.ncbi.nlm.nih.gov/pubmed/33828176
http://dx.doi.org/10.1038/s41598-021-87155-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027881/
https://www.ncbi.nlm.nih.gov/pubmed/33828176
http://dx.doi.org/10.1038/s41598-021-87155-5

Ejemplares similares